The possible role of aspirin in slowing cataract formation has been discussed both in the lay
pressl and in trade publications widely distributed to ophthalmologists. 2 Existing data are …

(Ophthalmology 1999; 106: 646–7). This surely depends on whether one regards cataract
as an eye disease responsible for more blindness worldwide than any other disease or as …

• A population-based cross-sectional survey of 838 men aged 30 years and over was
conducted to examine the effect of aspirin, and other potential risk factors, on the prevalence …

• Observational studies have raised the question of a possible benefit of aspirin on the
development of cataract. The Physicians' Health Study, a randomized double-masked …

• We examined the association between aspirin use and the rates of cataract extraction
during 8 years of follow-up in a large prospective study of women, the Nurses' Health Study …

PURPOSE: To examine whether low-dose aspirin (325 mg on alternate days) reduces the
risk of age-related cataract and subtypes. This report extends previous findings, including …

Background In Physicians' Health Study I, randomized trial results indicated no major
beneficial effect of 5 years of low-dose aspirin treatment on total cataract (relative risk [RR] …

A method is described for determining the natural progression of senile cataracts in humans
and whether certain factors accelerate or decelerate this progression. The method consists …

Materials and methods 72 Patients with senile cataract were operated. They are in the age
group of 50-70 years. They are divided into two groups A group which received preoperative …

The prevalence of cataracts is significanly lower in patients with rheumatoid arthritis
receiving aspirin (mean of 2,700 mgs daily for an average of 10.4 years) as compared to a …